ABBV Stock Analysis: Buy, Sell, or Hold?
ABBV - ABBVIE INC.
$223.01
2.58 (1.17%)
ā²
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
3d
Get Alerted When ABBV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š” BUY OPPORTUNITY: ABBV shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
š” BUY OPPORTUNITY: ABBV shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$435.40
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$270.35
17.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABBV is currently trading at $223.01, which is considered fair relative to its 30-day fair value range of $217.75 to $228.51. The stock's valuation (Forward PE: 15.5) is in line with its historical norms (15.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABBV is in a strong uptrend. The price is approaching resistance at $226.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $245.04 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABBV is in a strong uptrend. The price is approaching resistance at $226.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $245.04 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$217.75 -
$228.51
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($245.04)
Fair Price Analysis
30-Day Fair Range
$217.75 -
$228.51
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$209.96
Resistance Level
$226.86
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
15.48
Wall Street Target
$245.04
(+11.2%)
Revenue Growth (YoY)
9.1%
Earnings Growth (YoY)
-88.7%
Profit Margin
4.0%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
15.5 vs 15.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$219.33
(-1%)
2-Year Target
$218.23
(-1%)
3-Year Target
$217.14
(-2%)
3-Yr Target (if PE normalizes)
(PE: 15ā16)
$220.25
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 43.9%)
$946.97
(+330%)
Base:
(SPY PE: 15.5, Growth: 43.9%)
$657.29
(+198%)
Bear:
(PE: 13.2, Growth: 43.9%)
$558.69
(+154%)
š
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Forward PE: 15.58 | Forward EPS (Implied): $14.32
Bull Case
$269.28
(+21%)
Analyst growth 15.0%, PE expands to 16.4
Base Case
$223.01
(0%)
Market implied 0.0%, PE stable at 15.6
Bear Case
$170.60
(-24%)
Severe decline -15.0%, PE contracts to 14.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
š”
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.5 to 15.7
Stabilization Target:
$223.59
(+1.4%)
PE Expansion Potential:
+1.4%
Last updated: January 31, 2026 1:45 AM ET
Data refreshes hourly during market hours. Next update: 2:45 AM
Data refreshes hourly during market hours. Next update: 2:45 AM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABBV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
John Boozman
SELL
2025-08-22
Julie Johnson
SELL
2025-08-14
Azita Saleki-Gerhardt
SELL
42370 shares
2025-08-12
Featured in Portfolios
ABBV is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1111 | 60 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$135 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$332 | 66 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$192 | 58 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$115 | 60 HOLD |
Advanced ABBV Option Strategies
Professional options setups generated by AI based on today's ABBV price and gamma walls.
